Kymera Therapeutics, Inc. (KYMR) Analyst Estimates Annual - Discounting Cash Flows
KYMR
Kymera Therapeutics, Inc.
KYMR (NASDAQ)
Period Ending: 2029
12-31
2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
2023
12-31
2022
12-30
2021
12-30
2020
12-30
Number of Analysts 12 13 19 18 18 15 11 6 6 11
Estimated Revenue
Low 13.42 11.83 41.98 13.59 38.02 42.96 21.85 21.96 36.62 18.38
Average 54.41 47.96 42.17 46.7 53.21 53.87 88.55 50.19 83.71 42.01
High 124.2 109.4 42.36 115.5 102.1 107.4 202.1 107.7 179.7 90.18
Estimated EBITDA
Low -124.2 -109.4 -42.36 -115.5 -102.1 -107.4 -202.1 -150.8 -92.08 -90.18
Average -54.41 -47.96 -42.17 -46.7 -53.21 -53.87 -88.55 -125.7 -76.73 -42.01
High -13.42 -11.83 -41.98 -13.59 -38.02 -42.96 -21.85 -100.5 -61.38 -18.38
Estimated EBIT
Low -124.2 -109.4 -42.36 -115.5 -102.1 -107.4 -202.1 -154.5 -94.8 -90.18
Average -54.41 -47.96 -42.17 -46.7 -53.21 -53.87 -88.55 -128.7 -79 -42.01
High -13.42 -11.83 -41.98 -13.59 -38.02 -42.96 -21.85 -103 -63.2 -18.38
Estimated Net Income
Low -875.8 -387.8 -346.7 -331.4 -278.5 -236.7 -484.6 -153.4 -94.5 -268.5
Average -328.4 -314.1 -300.7 -283.8 -260.3 -199.2 -157.9 -127.9 -78.75 -107.8
High -6.81 -240.4 -254.6 -236.2 -242 -161.6 -3.77 -102.3 -63 -28.97
Estimated SGA Expenses
Low 10.79 9.51 33.76 10.93 30.57 34.55 17.57 32.39 22.98 14.78
Average 43.75 38.57 33.91 37.56 42.79 43.32 71.21 40.49 28.72 33.78
High 99.85 88.01 34.07 92.91 82.1 86.37 162.5 48.58 34.47 72.52
Estimated EPS
Low -11.67 -5.17 -4.62 -4.42 -3.71 -3.15 -6.46 -7.22 -4.64 -3.58
Average -4.38 -4.24 -4.06 -3.76 -3.53 -2.82 -2.42 -2.9 -1.86 -1.44
High -0.091 -3.2 -3.39 -3.15 -3.23 -2.15 -0.05 -0.779 -0.501 -0.386
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program